Successful Treatment with Dupilumab in a Patient with Severe, Difficult to Treat Atopic Dermatitis: Beware of Symptomatic Adrenal Insufficiency due to Abrupt Discontinuation of Potent Topical Corticosteroids
Saved in:
Main Authors: | Lieneke F.M. Ariëns (Author), Jorien van der Schaft (Author), Aline M.E. Stades (Author), Anthonie A. van de Woestijne (Author), Marjolein S. De Bruin-Weller (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid and Sustained Effect of Dupilumab on Work Productivity in Patients with Difficult-to-treat Atopic Dermatitis: Results from the Dutch BioDay Registry
by: Lieneke F.M. Ariëns, et al.
Published: (2021) -
Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment
by: Lieneke F.M. Ariëns, et al.
Published: (2019) -
Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index
by: Lieneke F.M. Ariëns, et al.
Published: (2019) -
Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
by: Shoko Miyamoto, et al.
Published: (2022) -
Abruptly Dogen
by: Smith, Kidder
Published: (2022)